TrialArthritis & rheumatology (Hoboken, N.J.)2019

Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen-Week Results From a Phase III Randomized, Double-Blind, Placebo-Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors.

Atul Deodhar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.